Indication
Gastric/Gastroesophageal Junction
1 clinical trial
2 products
Clinical trial
A Phase 1, Open-Label, Multicenter Study of INCB106385 as Monotherapy or in Combination With Immunotherapy in Participants With Advanced Solid TumorsStatus: Completed, Estimated PCD: 2024-02-22
Product
INCB106385Product
INCMGA00012